 | |
| Clinical data | |
|---|---|
| Other names | EiPT;N-Ethyl-N-isopropyltryptamine |
| Routes of administration | Oral[1] |
| Drug class | Psychedelic drug;Serotonergic psychedelic |
| ATC code |
|
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Duration of action | 4–6 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C15H22N2 |
| Molar mass | 230.355 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 71 to 73 °C (160 to 163 °F) |
| |
| |
| (verify) | |
Ethylisopropyltryptamine (EiPT), also known asN-ethyl-N-isopropyltryptamine, is apsychedelic drug of thetryptamine family.[1] It is takenorally.[1]
EiPT appears to have been firstsynthesized and described byAlexander Shulgin.[1]
In his bookTiHKAL (Tryptamines I Have Known and Loved),Alexander Shulgin lists the dose of EiPT as 24 to 40 mg and itsduration as 4 to 6 hours.[1] According to Shulgin, this compound tends to producenausea,dysphoria, and other unpleasantside effects.[1] It also seems to largely lack thehallucinatory andvisual properties usually associated with psychedelic drugs.[1]
EiPT is short forN-ethyl-N-isopropyltryptamine.[1] The full chemical name of this structure isN-ethyl-N-[2-(1H-indol-3-yl)ethyl]propan-2-amine. The compound is asubstituted tryptamine, which all belong to a larger family of compounds known asindolethylamines.[1] EiPT is closely related to the compoundsdiethyltryptamine (DET) andDIPT.[1]
Thechemical synthesis of EiPT has been described.[1]
EiPT is unscheduled and uncontrolled in theUnited States, but possession and sales of EiPT could be prosecuted under theFederal Analog Act because of its structural similarities to DET.[citation needed]
